# SBCapstone_CRISPRScreens

Goal of Capstone: investigate sensitivity and power of lethality based CRISPR screens. Focus on viability aspects of the screens.

## Current issues

Concerns about using data from the Israeli et al paper and the Cunha et al paper:

-   Lack off access to raw count data from both studies

-   Size imbalance:

    -   Israeli et al is a whole genome (roughly 20K genes targeted) and Cunha et al only targets 833 genes

-   The studies use different guides to target the genes (and only Israeli uses a publicly available library).

### Proposal

Switch to characterizing the guides and performance in the Sanson paper.

## Info from papers

+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
|                             | Sanson et al., 2018                                                                                                 | Israeli et al., 2022                                                                                                                                                                                                                                                                                                                                                                                                             | Cunha et al., 2023                                                                   |
+=============================+=====================================================================================================================+==================================================================================================================================================================================================================================================================================================================================================================================================================================+======================================================================================+
| **Main question of paper**  | Developing a new CRISPRko library that can more effectively distinguish between essential and non-essential genes.  | Understanding cellular factors involved in SARS-CoV-2 infection. (original variant, as well as Alpha and Beta variants)                                                                                                                                                                                                                                                                                                          | Understanding of cellular factors involved in SARS-CoV-2 infection.                  |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             | Note: they also look at CRISPRi and CRISPRa libraries, but we won't focus on that here.                             | Addressed:                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   Viability                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   Response to virus                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                      |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Cell line used**          | A375 melanoma cell lines                                                                                            | Calu-3 (human lung epithelial cell line)                                                                                                                                                                                                                                                                                                                                                                                         | Calu-3 (human lung epithelial cell line)                                             |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Cell numbers**            |                                                                                                                     | 4X10\^8                                                                                                                                                                                                                                                                                                                                                                                                                          | 50 million cells                                                                     |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Library used**            | Brunello                                                                                                            | Brunello CRISPR library                                                                                                                                                                                                                                                                                                                                                                                                          | Home brew                                                                            |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Guide information**       | -   Genome wide                                                                                                     | -   Genome wide                                                                                                                                                                                                                                                                                                                                                                                                                  | -   Targeting 833 genes                                                              |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             | -   77,441 sgRNAs                                                                                                   | -   76,441 sgRNAs                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             | -   average sgRNAs per gene                                                                                         | -   average 4 sgRNA/gene                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             | -   1000 non-targeting control RNAs                                                                                 | -   1000 non-targeting control RNAs                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                      |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Number of Replicates**    | 2-3                                                                                                                 | 2                                                                                                                                                                                                                                                                                                                                                                                                                                | 2                                                                                    |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Controls**                |                                                                                                                     | non-infected cells grown for 7 days                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                      |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Sequencing**              | <https://www.ncbi.nlm.nih.gov/sra/PRJNA508200>                                                                      | unavailable                                                                                                                                                                                                                                                                                                                                                                                                                      | unavailable                                                                          |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Experimental conditions** | Transduction:                                                                                                       | Infections:                                                                                                                                                                                                                                                                                                                                                                                                                      | Infections:                                                                          |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             | -   MOI of \~0.5                                                                                                    | SARS-CoV-2 WT                                                                                                                                                                                                                                                                                                                                                                                                                    | SARS-CoV-2 WA! strain                                                                |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             | -   On average 500 unique cells/sgRNA                                                                               | SARS-CoV-2 B.1.1.7 (Alpha)                                                                                                                                                                                                                                                                                                                                                                                                       | For infected samples:                                                                |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             | Comparing to gold standard set of 'known' 1580 essential genes and 927 non-essential genes.                         | SARS-CoV-2 B.1.351 (Beta(                                                                                                                                                                                                                                                                                                                                                                                                        | -   Infected at MOI of 0.3                                                           |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | For infected samples:                                                                                                                                                                                                                                                                                                                                                                                                            | -   Puromyocin added at 1 day post transduction                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   Infected at an MOI of 0.3                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   2 days post transfection, added puro to select for cells that got an integration                                                                                                                                                                                                                                                                                                                                             |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   Grown for 7 days post puro                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   For a control reference for sgRNA, enrichment analysis cells were harvested 48 h post seeding                                                                                                                                                                                                                                                                                                                                |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | For viability                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   Mock cells harvested 7 days after seeding                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | Estimating each guide should be represented in \~400 cells.                                                                                                                                                                                                                                                                                                                                                                      |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | sgRNA abundance determined by sequencing                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                      |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| **Analysis software**       |                                                                                                                     | MAGeCK v0.5.6                                                                                                                                                                                                                                                                                                                                                                                                                    | PoolQ to map individual reads to the reference gRNA sequence and id sample barcode.  |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   Count sgRNA from FASTQ                                                                                                                                                                                                                                                                                                                                                                                                       | Used MAGeCK to do gene enrichment.                                                   |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   Uses Robust Rank Algorithm to look at selection effects                                                                                                                                                                                                                                                                                                                                                                      | FDR of \<0.5                                                                         |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | -   Directed score for each gene was calculated by taking the enrichment MAGeCK RRA score for genes with a positive fold change from control and teh depliction MAGeCK RRA score for genes with a negative or zero fold change. Directed scores for sgRNAs were calculated by multiplyt the MAGeCK sgRNA scores by 1 or (-1) according to the direction of the change. The scores were scaled to sd=1 and centered on the mean.  |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | Genes and their enrichment scores can be found in Supplementary Data 1.                                                                                                                                                                                                                                                                                                                                                          |                                                                                      |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+
| Data                        |                                                                                                                     | sgRNA count raw data: GSE197962                                                                                                                                                                                                                                                                                                                                                                                                  | Supplemental table S2: CRISPR Screen gRNA level analysis                             |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     | Processed screen data in Supp. data 1-3                                                                                                                                                                                                                                                                                                                                                                                          | Supplemental table S3: CRISPR screen gene level analysis preinfction                 |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  | Supplemental table S4: CRISPR screen gRNA level analysis post infection              |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                      |
|                             |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                  | Supplemental table S5: Raw data for statistical analysis                             |
+-----------------------------+---------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+

## Data files fro BioGRID ORCs and/or Papers

+---------------------+-----------------------------------------+---------------------------------------------------------+
|                     | File                                    | Description                                             |
+=====================+=========================================+=========================================================+
| Cunha et al., 2023  | BIOGRID-ORCS-5622-1.1.16.screen.tab.txt | Table from BioGrid ORCs                                 |
+---------------------+-----------------------------------------+---------------------------------------------------------+
|                     | jv.01276-23-s0004.xlsx                  | Supplemental table 4 (plasmid vs. d0 gene)\             |
|                     |                                         | MAGeCK output                                           |
+---------------------+-----------------------------------------+---------------------------------------------------------+
| Israeli et al, 2022 | BIOGRID-ORCS-5622-1.1.16.screen.tab.txt | Table from BioGrid ORCs                                 |
+---------------------+-----------------------------------------+---------------------------------------------------------+
|                     | PMID35469023-SuppData3.xlsx             | Supplemental table 3                                    |
|                     |                                         |                                                         |
|                     |                                         | MAGeCK output                                           |
+---------------------+-----------------------------------------+---------------------------------------------------------+
|                     | GSE197962_sgRNA_counts.txt              | Guide counts from                                       |
+---------------------+-----------------------------------------+---------------------------------------------------------+
|                     | broadgpp-brunello-library-contents.txt  | guide-gene mapping                                      |
+---------------------+-----------------------------------------+---------------------------------------------------------+
|                     | brunello_plasmid_counts                 | Initial info on plasmid and guide counts in A375 screen |
+---------------------+-----------------------------------------+---------------------------------------------------------+
| Sanson et al., 2018 | 41467_2018_7901_MOESMA_ESM.xlsx         | Supplmentary table 1 (raw counts for KO)                |
+---------------------+-----------------------------------------+---------------------------------------------------------+

## Algorithms and approaches for analyzing CRISPR KO libraries

Mostly from Zhao et al, 2022

### Brief Description of MAGeCK 

from Li et al., 2014 (original paper describing MAGeck)

1.  Read counts from different samples are median normalized to adjust for the effect of library sizes and read count distributions.

2.  The variance of read counts is estimated by sharing information across features

3.  A negative binomial model is used to test whether sgRNA abundance differs significantly between treatments and controls

    1.  Used sgRNAs based on P-values calculated from the negative binomial model

    2.  Used a modified robust ranking aggregation (RRA) algorithm to identify positively and negatively selected genes- alphaRRA

        1.  alphaRRA assumes that if a gene has no effect on select, then sgRNAs targeting this gene should be uniformly distributed across the ranked list of all sgRNAs.

4.  alphaRRA ranks genes by comparing the skew in rankings to the uniform null model and prioritizes gens whose sgRNA rankings are consistently higher than expected.

5.  alphaRRA calculates the skew by permutation

### ScreenBEAM

Use linear model equivalent to a students t-statistics to test significance of the coefficient.

### BAGEL

Used a predefined list of essential and non-essential genes. Estimated the sgRNA fold change for these genes using a kernel density estimate function. Then BAGEL evaluates the probability that the abundance changes of all sgRNAs for one gene were extracted from the essential gene or non-essential gene distribution.

### PBNPA

Computed a p-value at the gene level by the permutation test, with no-distribution assumptions.

### JACKS

Bayesian method: model sgRNA efficiencies by obtaining information from multiple screens utilizing the same sgRNA library design.

### gscreend

Focused on accurate modeling of read count distribution in SCRISPR screens. Compared abundance just from the culturing process- found that before/after ratios for control guides are not asymmetric in KO screens- influenced by cell proliferation and width of sgRNA abundance distribution- so a skew normal distribution is use to estimate the null distribution.

## Things that may impact the data

-   Guide counts general exhibit overdispersion

-   Sequecing depth

-   Gene Expression

-   Selection approach

-   Guide efficiency